
Capillary Technologies India Ltd opened its Initial Public Offering (IPO) today on November 14, 2025 for public subscription. The bidding window for the Capillary Technologies IPO will remain open till November 18, 2025. The IPO allotment process is expected to be finalised on November 19, 2025, and the shares will be listed on both NSE and BSE. The tentative listing date is set for November 21, 2025.
Founded in 2008, Capillary Technologies is a Bengaluru-based SaaS company that provides AI-powered customer loyalty and engagement solutions. The company serves brands across retail, aviation, hospitality, BFSI, and other consumer-facing sectors, with a strong global presence across North America, EMEA, and the Asia-Pacific region.
Capillary Technologies IPO is a book-built issue of ₹877.50 crore. The issue comprises a fresh issue of ₹345 crore and an offer for sale (OFS) of 0.92 crore shares aggregating to ₹532.50 crores by existing shareholders.
The IPO price band is set between ₹549 to ₹577 per share. The minimum lot size for an application is 25, with the minimum investment for retail investors is ₹14,425 based on the upper band.
JM Financial Limited, IIFL Capital Services Limited (formerly known as IIFL Securities Limited) and Nomura Financial Advisory and Securities (India) Private Limited are the book-running lead managers to the issue. MUFG Intime India Private Limited (Formerly Link Intime India Private Limited) is the registrar for the IPO.
[November 14, 2025, 02:12 PM]
On Day 1, Capillary Technologies IPO saw a subscription of 0.27 times.
The public issue was subscribed:
Explore other Upcoming IPOs on BSE and NSE.
The company plans to utilise the net proceeds from the fresh issue towards:
Check out newly Listed IPOs on BSE and NSE.
Capillary Technologies is a global SaaS leader in loyalty management, customer data platforms, and engagement automation. The company works with over 250 brands across 30+ countries and derives a major share of its revenue from international markets, particularly North America.
Financially, the company reported:
Disclaimer: This news is solely for educational purposes. The securities/investments quoted here are not recommendatory.
To read the RA disclaimer, please click here